Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N07 OTHER NERVOUS SYSTEM DRUGS
N07X OTHER NERVOUS SYSTEM DRUGS
N07XX Other nervous system drugs
N07XX08 Tafamidis
D09674 Tafamidis meglumine (JAN/USAN) <JP/US>
USP drug classification [BR:br08302]
Genetic, Enzyme, or Protein Disorder: Replacement, Modifiers, Treatment
Tafamidis
D09674 Tafamidis meglumine (JAN/USAN)
Therapeutic category of drugs in Japan [BR:br08301]
1 Agents affecting nervous system and sensory organs
12 Agents affecting peripheral nervous system
129 Miscellaneous
1290 Miscellaneous
D09674 Tafamidis meglumine (JAN/USAN)
2 Agents affecting individual organs
21 Cardiovascular agents
219 Miscellaneous
2190 Miscellaneous
D09674 Tafamidis meglumine (JAN/USAN)
Target-based classification of drugs [BR:br08310]
Transporters
Other transporters
Others
TTR
D09674 Tafamidis meglumine (JAN/USAN) <JP/US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D09674
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D09674
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D09674